Información de la revista
Editorial
Original articles
Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy in a referral center in Spain
J. Larrea, R.M. Sánchez-Ávila, E. Villota-Deleu, A. Fernández-Vega Sanz
Arch Soc Esp Oftalmol. 2022;97:603-11
Evaluation of clinical and functional sequels of central serous chorioretinopathy. A case series analysis
A.M. Cerón Enríquez, O.L. Teherán Forero, C. Atencia Niño, R. Almanza Benito Revollo, E.C. Ramos Clason, M.M. Ochoa Díaz
Arch Soc Esp Oftalmol. 2022;97:612-9
Choroidal occlusive vasculopathy after intraarterial chemotherapy: MRI findings
M. Roca-Cabau, J. Peralta Calvo, F. García Martínez, A. López-Vázquez, O. D’Anna
Arch Soc Esp Oftalmol. 2022;97:620-5
Guidance on brolucizumab management recommendations
A. Fonollosa, R. Gallego-Pinazo, L. Sararols, A. Adán, M. López-Gálvez, M.S. Figueroa
Arch Soc Esp Oftalmol. 2022;97:626-38
Open access
Artículo abierto
OCT angiography biomarkers in type 1 choroidal neovascularisation after one year of aflibercept treatment
R. Campos Polo, I. Gómez Sánchez
Arch Soc Esp Oftalmol. 2022;97:639-45
Review
Prematurity: A medical history of obligatory consideration when assessing the retinal ganglion cell complex
A. Ortueta-Olartecoechea, J.L. Torres-Peña, A. Muñoz-Gallego, C. López-López, S. Vázquez Román, P. Tejada-Palacios
Arch Soc Esp Oftalmol. 2022;97:646-54
Short communication
Autoimmune retinopathy with onconeuronal antibodies: Case report
B. Alamar Pérez, M.L. Hernández Garfella, V. Castro Navarro, C. Monferrer Adsuara, J. Montero Hernández, E. Cervera Taulet
Arch Soc Esp Oftalmol. 2022;97:655-8